Recall: D-0857-2018

Class III - Minor Violations

Class IIIClassification

2018-04-30Initiated

TerminatedStatus

Teva Pharmaceuticals USAFirm

Product

Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)

Reason

Failed Stability Specifications

Distribution

United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.